LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹4.29 Cr | ₹3.83 Cr | ₹4.01 Cr | ₹4.23 Cr | ₹-16 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of LYKA LABS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹4.29 Cr |
| Mar2024 | ₹3.83 Cr |
| Mar2023 | ₹4.01 Cr |
| Mar2022 | ₹4.23 Cr |
| Mar2021 | ₹-16 Cr |
How is Deferred Tax Assets / Liabilities of LYKA LABS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.29 Cr | 12.15 | |
| Mar2024 | ₹3.83 Cr | -4.54 | |
| Mar2023 | ₹4.01 Cr | -5.27 | |
| Mar2022 | ₹4.23 Cr | Positive | |
| Mar2021 | ₹-16 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹291.9 Cr | 9.7% | -1.9% | -51.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹414,929.0 Cr | 0.7% | -4.2% | -8.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,644.0 Cr | 0% | -1% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹131,481.0 Cr | 2.4% | 4.5% | 14.5% | Stock Analytics | |
| CIPLA | ₹122,050.0 Cr | 1.1% | 0.2% | -1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,784.0 Cr | -1% | -2% | -9.7% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | 9.7% |
-1.9% |
-51.1% |
| SENSEX | 0.9% |
0.7% |
9.6% |
You may also like the below Video Courses